Skip to content
TrialScanner

NCT03621982

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Phase 1TerminatedADCTLead

Registry record

Lead sponsor
ADC Therapeutics S.A.
Conditions
Head and Neck Cancer Squamous Cell Carcinoma; Non-small Cell Lung Cancer; Gastric Cancer; Esophageal Cancer; Pancreas Cancer
Primary completion
Dec 14, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03621982 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03621982: Study of ADCT-301 in... | TrialScanner